ARTICLE | Company News
FDA panel to review Uniprost NDA
November 9, 2000 8:00 AM UTC
The FDA's Cardiovascular and Renal Drugs Advisory Committee will review early next year the NDA for United Therapeutics' Uniprost ( UT-15) modified prostacyclin to treat pulmonary arterial hypertensio...